Three-dimensional models of thrombin complexed with large fragments of the fibrinogen A␣ and B␤ chains are presented. The models are consistent with the results of recent mutagenesis studies of thrombin and with the information available on naturally occurring fibrinogen mutants. Thrombin recognizes fibrinogen with an extended binding surface, key elements of which are Tyr 76 in exosite I, located about 20 Å away from the active site, and the aryl binding site located in close proximity to the catalytic triad. A highly conserved aromatic-Pro-aromatic triplet motif is identified in the primed site region of fibrinogen and other natural substrates of thrombin. The role of this triplet, based on the three-dimensional models, is to correctly orient the substrate for optimal bridge binding to exosite I and the active site. The three-dimensional models suggest a possible pattern of recognition by thrombin that applies generally to other natural substrates.
Thrombin plays multiple functional roles in the blood by interacting with a variety of proteins. The procoagulant role of thrombin unfolds upon interaction with fibrinogen and culminates in the formation of fibrin intermediates that polymerize into a blood clot. The kinetic steps defining this interaction and the mechanism of fibrin polymerization have been characterized in great detail (1) . The determinants of fibrinogen recognition by thrombin have also been elucidated by site-directed mutagenesis (2, 3) and provide an important data base of information that complements clinical findings of naturally occurring fibrinogen variants that are associated with bleeding phenotypes.
The thrombin-fibrinogen interaction has enjoyed renewed interest in recent years after the landmark solution of the crystal structure of fibrinogen derivatives (4 -7). These structures have offered clues about the molecular events underlying the end-to-end assembly of fibrin monomers generated after the thrombin-induced release of FpA 1 from the A␣ chain, the subsequent formation of fibrin protofibrils, and the thrombininduced release of FpB from the B␤ chain (4) . Information about the structural epitopes of thrombin recognizing fibrinogen has also been obtained. Fragments of FpA covalently bound to the active site Ser 195 of thrombin have been reported by x-ray crystallography (8, 9) and NMR spectroscopy (10) . These studies have delineated the interactions made by FpA with the active site moiety of thrombin.
It has long been known, however, that regions of thrombin distant from the active site are involved in fibrinogen recognition (11) . Specifically, exosite I, which is located about 20 Å away from the active site, contains residues that are critical for fibrinogen binding. Macromolecular bridge binding of fibrinogen to exosite I and the active site confers high specificity to the interaction and serves as a binding mode exploited by other natural substrates like the G-protein-coupled thrombin receptors (3). Recent Ala-scanning mutagenesis studies of thrombin have identified a hot spot in exosite I, centered near Tyr 76 , which stores much of the energy responsible for the interaction with fibrinogen (2, 3) . Unfortunately, the available crystal structure of the thrombin-fibrinogen complex does not provide information about the contacts made by the natural substrate with exosite I. In the case of the interaction of thrombin with the B␤ chain of fibrinogen that is responsible for the release of FpB and protofibril polymerization, no structural information is currently available.
This study fills an important structure-function gap in our understanding of the thrombin-fibrinogen interaction. Here we report about three-dimensional models of thrombin complexed with large fragments of the A␣ and B␤ chains of fibrinogen following a strategy recently used in the case of thrombin interaction with the G-protein-coupled receptors PAR1, PAR3, and PAR4 (3). The models are highly consistent with available data on site-directed and naturally occurring mutants of thrombin and fibrinogen.
MATERIALS AND METHODS
The N-terminal fragments of the fibrinogen A␣-(20 -62) and B␤-(31-72) chains were built, capped, and completed for missing hydrogens (pH 7.0) with Biopolymer and InsightII (Accelerys, San Diego, CA) using the human sequences P02671, P02675, and P02679 from the SwissProt sequence data base (12) . First, 500 models were produced with Modeler4 (13) by comparative modeling of every substrate on the surface of thrombin using several available crystal structures of peptide-thrombin complexes as templates. Substrate conformation was then optimized from the best model by simulated annealing during molecular dynamic processes with Discover (Accelerys).
The fibrinogen fragment A␣-(26 -35) was threaded over the Ac-DFLAEGGGVR peptide from the x-ray crystal structures 1BBR and 1UCY (9, 14) . Residue Arg 35 of the A␣ chain was linked through its carbonyl oxygen to thrombin Ser 195 ⌷␥ to form a reaction intermediate analogous to the Arg of PPACK in 1PPB (15) . The conformation of fragment A␣-(35-49) was templated on the protein fragments KILD-KVVERIKERMKDSNVKL from 1A0E and AFWRELVECFQKISKDS-DCRA from 1DCI. These fragments were selected from our data base of 48 million conformers constructed by fragmenting the entire protein data bank into peptides from 3 to 18 residues in length. The conformers were screened for optimal shape, length, and fit to the thrombin surface. The conformation of fragment A␣-(46 -57) was loosely threaded over the NGDFEEIPEEYL hirugen peptide from the structures 1HAH (16) and 1NRS (17) . The fibrinogen fragment B␤-(41-44) was threaded over the peptide LDPR from the structure 1NRS (17) . Residue Arg 44 of the A␣ chain was linked through its carbonyl oxygen to thrombin Ser 195 O␥ as described previously. The conformation of fragment B␤4-(49 -61) was loosely threaded over the NGDFEEIPEEYL hirugen peptide from structures 1HAH and 1NRS and also over the proline-rich peptide APTMPPPLPP from the structure 1ABO of a tyrosine kinase Src homology domain 3 (18) .
Peptides were docked over thrombin using 1PPB and 1HAH as templates and yielded 500 models that were ranked in terms of stereochemistry quality and lowest potential binding energies. Models containing a ligand with a root mean square deviation within 2 Å from one with a better rank were eliminated. We selected the best 10 models, extracted the ligand, and docked it over thrombin in 1PPB as a starting point. Water molecules and Na ϩ as defined in 1HAH and 1PPB were pooled and filtered for overlaps with thrombin or ligand atoms and added to the starting model. The backbone of thrombin secondary structures templated on 1PPB was kept frozen during simulated annealing applied by molecular dynamics in cartesian space (fast annealing from 50 to 600 K in 3 ps, slow cooling from 600 to 50 K over 10 -30 ps with progressive constraint to bring back the thrombin backbone to the 1PPB reference). Models were sampled every 1 ps. About 300 models (10 starts and 30 samples per trajectory) were minimized (200 steepest descent, 1500 conjugate gradient cycles). All processes were performed with the force field CFF91 and Discover. Constraints were used to hold the Na ϩ coordination shell in place. The dielectric constant was set at 1 ϫ r. Cutoffs were used to threshold noncovalent bonds at 14 Å during Monte Carlo processes and dynamics. Cutoffs were set to infinite during minimizations.
Models of thrombin-substrate complexes with a root mean square deviation of less than 1.5 Å for the thrombin backbone and peptide residues less than 10 Å from the enzyme were considered acceptable. The stereochemistry of final conformations was systematically checked with Procheck 3.0 (19) to satisfy a quality expected for a 2.4-Å resolution model (the lowest resolution of the structures that we used as template). The solvent-accessible surface of thrombin was calculated according to the Connolly algorithm and rendered as a solid surface with InsightII using a 1.4-Å radius probe.
Thrombin mutations were modeled with Biopolymer. Dihedral angles were explored with the Monte Carlo/Metropolis method for the main chains of the wild-type residue, its flanking residues, and the side chains of residues within 6 Å from the site of mutation. Minimizations were run in two steps with Discover using the force field CFF91 and keeping the constraints on the Na ϩ and its coordination shell. A steepest descent algorithm was applied over 300 cycles, followed by a conjugate gradient algorithm for as much as 1500 cycles.
Thrombin sequences were selected from the nonredundant sequence data base (NCBI, Bethesda, MD) with the BLAST program (20) and aligned with Clustal X (21). Sequences of thrombin natural substrates were aligned according to the best model, threaded, and docked on the thrombin surface as described previously using one substrate fragment per orthologous group of sequences. Other orthologous sequences were aligned over the multialigned sequence core with Clustal X.
RESULTS
Interaction with the A␣ Chain-The biggest fragment from fibrinogen crystallized with thrombin is the FpA (11) (12) (13) (14) (15) (16) (17) (18) (19) from bovine equivalent to the human FpA (27-35) (9). A␣-(26 -39) is the longest fragment from human fibrinogen bound to thrombin studied by NMR (10) . Hirugen peptides inhibit fibrinogen cleavage by binding to exosite I (16) . We used these peptides as templates to model A␣-(43-54). The three structures 1BBR, 1UCY, and 1HAH helped build the core 27 FLAEGGGVRGPRV-VERHQSACKDSDWPF 54 of the human A␣-(20 -62) fragment. Equivalent positions of the human A␣-(20 -62) residues are not visible in the crystal structure of the bovine fibrinogen A␣ chain (5, 8) . The first documented motif is a helix starting at position 63 according to the corresponding human chain numbering. The helix end is accessible to solvent, and we therefore assumed that the N-terminal fragment amino acids 1-62 folds in a way that is accessible to thrombin. The fragment is probably responsible for most of the interactions between fibrinogen and thrombin because A␣-(20 -70), produced by the cyanogen bromide hydrolysis of fibrinogen, is as good a thrombin substrate as the entire fibrinogen (22, 23) . We extended the templated peptide core to A␣-(20 -62) and docked it on thrombin.
The peptide is mainly in extended conformation with two short loops 28 -33 (loop 1) and 39 -48 (loop 2).
The A␣ chain fragment explores different portions of the thrombin surface (Fig. 1) . Residues 20 -25 interact with exosite II. Residues 26 -38 fit into the active site. Residues 39 -51 bind to the groove connecting the active site with exosite I, and residues 52-62 dock onto exosite I. The change in exposed surface area upon formation of the complex between thrombin and A␣-(20 -62) is 3501 Å 2 (25% of the thrombin surface), comparable to 3304 Å 2 in the thrombin-hirudin interface (24) . Half of the contact area maps outside the region from the aryl binding site to the S3Ј site framing the portion of substrate interacting with the active site. The relevant contacts of the A␣-(20 -62)-thrombin complex are reported in Fig. 2 and are compared with those of the templates.
There is a site of phosphorylation in the human fibrinogen A␣ chain at A␣-Ser 22 that results in an intermediate showing higher specificity for thrombin (25) . Analysis of the 31 P onedimensional NMR spectral changes caused by the synthetic phosphorylated peptide A␣-(20 -41) binding to thrombin suggests that this group contributed to binding (26 (28) . A three-dimensional model of thrombin complexed with the A␣ chain carrying the F27Y mutation shows that the hydroxyl group of A␣-Tyr 27 H-bonds to the nitrogen atom of A␣-Val 34 , fixing the aromatic ring of A␣-Tyr 27 into a distorted position that pulls thrombin Trp 215 1.4 Å higher and out of the aryl binding site (Fig. 3) . This perturbation increases the solvent exposure of the hydrophobic surface of the entire aryl binding site. Similar perturbations of Trp 215 have been shown to produce drastic (up to 500-fold) reductions in clotting activity (29) . Furthermore, the steric hindrance introduced in the thrombin mutant L99Y skews the A␣-Phe 27 39 . The energetic contribution of this ion pair is modest because the E39A mutant of thrombin has clotting activity comparable to wild type (3), and the fibrinogen mutants A␣-R38S Detroit (38) , A␣-R38G Aarhus (39) , and A␣-R38N Munich (40) have normal or slightly reduced clotting activity.
The A␣ and B␤ chains have a loop segment between the anchor positioned into the S1 pocket and the region binding to exosite I. Within this loop, A␣-Cys 47 is exposed to solvent in the A␣-(20 -62)-thrombin complex and is available for a disulfide bridge with A␣-Cys 47 from the second A␣ chain of the fibrinogen dimer.
A␣-Asp 51 is ion-paired with Arg 67 in exosite I. The mutation R67A equally affects FpA and FpB release (3), although there is no residue in the B␤ chain available for an ion pair with The thrombin surface is color coded to reflect the extent of perturbation induced by the mutation of specific residues (labeled in the top panels) on the value of the specificity constant k cat /K m for the release of FpA or FpB (3). The following scale is used: red (Ϫ3.5 to Ϫ2.5 log units), orange (Ϫ2.5 to Ϫ1.5 log units), green (Ϫ1.5 to Ϫ0.5 log units), cyan (Ϫ0.5 to 0.5 log units), and blue (0.5 to 1.5 log units). Residue Lys 70 is buried under Tyr 76 in exosite I and is not visible.
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Arg 67 . That suggests that the loss of thrombin activity toward the A␣ and B␤ chains is due to perturbation of the buried ion-pair quartet involving Arg 67 , Lys 70 , Glu 77 , and Glu 80 , which holds the 70-loop and the all important residue Tyr 76 in their correct conformation (15) . Indeed, the mutants R67A, K70A, E77A, and E80A alter the kinetics of FpA and FpB release drastically and to the same extent (3), even though Lys 70 and Glu 80 do not contact the A␣ or B␤ chains. Furthermore, the effect of these mutations is practically identical to that caused by the Y76A mutation (3), suggesting that the role of the buried quartet is to orient Tyr 76 on the surface of the 70-loop for optimal interaction with fibrinogen.
The Interaction with the B␤ Chain-The peptide B␤-(31-148) produced by cyanogen bromide hydrolysis is not as good a substrate as the entire B␤ chain (41) . We templated the conformation of 41 FSAR 44 of the B␤ chain by homology with the peptide LDPR complexed with thrombin in 1NRS (17) . The B␤ chain also shows a highly conserved proline-rich region in the range of contact with thrombin. The structures of LDPR-hirugen-thrombin 1NRS (17), hirugen-thrombin 1HAH (16) , and APTMPPPLPP bound to the SH3 domain 1ABO (18) were used to build the core 41 FSARGHRPLDKKREEAPSLRPAPPP 65 of the human B␤ chain fragment. We extended the peptide over its two ends to make a three-dimensional model of the fragment B␤-(31-72) bound to thrombin. This portion of the B␤ chain is not visible in the available crystal structures (5, 7). The first motif visible is a helix starting at position 77 in the corresponding human chain numbering.
As for the A␣ chain, the B␤ chain makes contact with an extended surface of thrombin (Fig. 1) . Residues 31-39 contact exosite II. Residues 40 -47 bind to the active site. Residues 

DISCUSSION
The three-dimensional models of thrombin bound to fragments of the human fibrinogen A␣ and B␤ chains are consistent with available data on site-directed mutagenesis of thrombin and with the phenotype observed with several naturally occurring mutants of fibrinogen. These models also make it possible to align the sequences of fibrinogens from other species and other thrombin natural substrates around their cleavage site. The alignment (Fig. 4) suggests a pattern of recognition by thrombin that applies generally to other natural substrates. The loops 1 and 2 fix the docking into the active site and groove region. In the case of the fibrinogen A␣ chain, loop 2 also provides room for the disulfide bridge with the homologous A␣ chain via A␣-Cys 47 . Acidic residues are frequently found in the region of the unprimed sites that bind to exosite II. A hydrophobic/aromatic residue fills systematically the aryl binding site as documented in the crystal structures of thrombin bound to FpA (8, 9) or PAR1 (17) . A hydrophobic side chain often precedes the residue bound to the aryl binding site (see for example the A␣ and B␤ chains of fibrinogen). The added hydrophobicity from this side chain provides optimal packing against the aromatic moiety of W60d. In the primed sites the P2Ј position is often occupied by Phe, Tyr, His, or Pro (noted in Fig. 4 ) to frame the ring of W60d in sandwich with a Pro often found in the P2 position. Furthermore, a Pro residue is often located downstream of the site of cleavage in a position to contact exosite I and appears to be highly conserved among all thrombin substrates, with the exception of factor V, factor XIII, and TAFI. The role of this Pro (residue 53 in the case of the A␣ chain) is to kink the substrate backbone into exosite I at the thrombin surface. Hydrophobic/aromatic residues often flank this Pro (e.g. A␣ chain, PAR3, and factor XI), and the A␣-(20 -60)-thrombin model indicates that the role of this aromaticPro-aromatic triplet is to cage Tyr 76 for optimal bridge binding of exosite I and the active site.
There are 838 examples of aromatic-Pro-aromatic triplets in the protein data bank. 20% of the examples show the aromatic residues pointing in the same direction, and caging another aromatic side chain in 5% of the cases. Interestingly, a screening of all sequences in the S1 family of serine proteases shows the presence of a Pro residue located 13 residues downstream from the activation cleavage site in 83% of the cases (the Pro is at position 27 with the standard chymotrypsin numbering). The origin of this conservation is unclear, although the analogy with thrombin substrates discussed above should draw attention to a possible "universal" role of this residue in optimizing the alignment of unprimed residues of substrate for cleavage by the target protease. Site-directed mutagenesis of this conserved Pro in different systems will be necessary to test this hypothesis.
